Atlas Trials

Brain Irradiation and Tremelimumab in Metastatic Breast Cancer

Clinical trial NCT02563925 · COMPLETED

Trial details

NCT number
NCT02563925
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2015-09-18
Primary completion
2021-07-14
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.